Attkisson reports that one of the authors of that Veteran’s hydroxychloroqine report received a $247,000 grant from Gilead in 2018.
“I think you have to look at the money, says Dr. Orient, “There is no big money in hydroxychloroquine.”
When Full Measure cross-referenced those on the U.S. COVID-19 Advisory Board with links to drug companies, they found 11 members. Of those 11, nine members were linked to Gilead.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Separation of Big Pharma and State!